Edition:
United Kingdom

Pharmaceuticals

Celgene Says FDA Approves Otezla (Apremilast) For Treatment Of Oral Ulcers Associated With Behçet’s Disease

July 19 (Reuters) - Celgene Corp ::FDA APPROVES OTEZLA® (APREMILAST) FOR THE TREATMENT OF ORAL ULCERS ASSOCIATED WITH BEHÇET’S DISEASE.CELGENE CORP - FDA APPROVAL WAS BASED ON EFFICACY AND SAFETY RESULTS FROM RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND PHASE 3 RELIEF STUDY.CELGENE CORP - U.S. FDA...

6:59pm BST

Bayer Statement On Voluntary Recall Of Two Lots Of Kogenate FS Antihemophilic Factor In U.S.

July 19 (Reuters) - Bayer::BAYER STATEMENT ON VOLUNTARY RECALL OF TWO LOTS OF KOGENATE® FS ANTIHEMOPHILIC FACTOR (RECOMBINANT) IN THE UNITED STATES.BAYER - THERE ARE NO LOTS OF JIVI OR KOVALTRY(®) ANTIHEMOPHILIC FACTOR (RECOMBINANT) PRODUCT AFFECTED BY RECALL.BAYER-WHILE MAJORITY OF MISLABELED VIALS...

6:32pm BST

Health Canada Says Pfizer Confirms EpiPen 0.3 Mg Supply Is Currently Available And Continues To Be Shipped

July 19 (Reuters) - Health Canada::HEALTH CANADA - PFIZER HAS CONFIRMED THAT EPIPEN 0.3 MG SUPPLY IS CURRENTLY AVAILABLE AND CONTINUES TO BE SHIPPED.HEALTH CANADA - PFIZER IS REPORTING THAT IT ESTIMATES EPIPEN 0.3 MG SUPPLY ISSUE WILL BE FULLY RESOLVED IN EARLY OCTOBER 2019.HEALTH CANADA - PFIZER...

4:42pm BST

Statement From Health Canada On The Supply Of EpiPen 0.3 Mg Auto-Injectors

July 19 (Reuters) - Health Canada::STATEMENT FROM HEALTH CANADA ON THE SUPPLY OF EPIPEN 0.3 MG AUTO-INJECTORS.HEALTH CANADA - EPIPEN JR (0.15 MG) IS NOT AFFECTED BY SHORTAGE.HEALTH CANADA - AWARE THAT PFIZER CANADA IS REPORTING THAT A SHORTAGE OF 0.3 MG FORMAT EPIPEN AUTO-INJECTOR MAY LEAD TO...

3:48pm BST

Expansion & New Markets

Markets

  • Sectors
  • Europe
  • U.S.
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.